Main glossary
Special | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | ALL
I |
---|
in silicoPerformed on computer or via computer simulation | |
in vitroWhen a study is performed with microorganisms,
cells or molecules outside of their normal biological context | |
in vivoWhen a study tests the effect of drugs on
whole, living organisms | |
InclusionNot everyone is applicable to take part in a clinical trial. Volunteers can be included for a number of reasons such as age, gender, type of condition, and other symptoms. | |
Incremental cost-effectiveness ratioA measure of the economic value of an intervention, in terms of costs and health benefits, compared with an alternative (comparator). It is usually the main output or result of an economic evaluation. | ||
Indication | |
Informed consentInformed consent requires trial participants to be provided with a clear explanation of the trial and associated risks and benefits to make a fully informed decision about participating. | |
Intellectual propertyDenotes ownership of an idea and can include
copyrights, patents and trademarks | |
InterventionA treatment option such as a drug, type of
surgery, or medical device. | |
InterventionA treatment option such as a drug, type of
surgery, or medical device | |
Social networks